- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00722891
Ocular Responses to Short and Long-term Lens Wear
November 24, 2019 updated by: Bausch & Lomb Incorporated
Ocular Responses to Acute and Chronic Lens Wear
The purpose of this study was to determine whether ocular surface sensitivity to pneumatic, mechanical and chemical stimulation would be affected by the use of the combination of a specific silicone hydrogel lens material with two lens care products over a four week period.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is at least 17 years old and has full legal capacity to volunteer;
- Is correctable to a visual acuity of 6/7.5 (20/25) or better (both eyes) with their habitual vision correction;
- Is a current soft lens wearer and wears contact lenses six or more days/week;
- Has clear corneas and no active ocular disease.
Exclusion Criteria:
- Has any clinically significant blepharitis or dry eye;
- Has undergone corneal refractive surgery;
- Is aphakic;
- Has any active ocular disease;
- Has any systemic disease affecting ocular health;
- Is using any systemic or topical medications that may affect ocular health;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Purevision Lens with ReNu
Purevision Lenses with ReNu Multiplus Solution
|
Purevision lenses using ReNu Multiplus lens solution for 28 days
Other Names:
|
|
Active Comparator: Purevision Lenses with RepleniSH
Purevision Lenses with Optifree RepleniSH Solution
|
Purevision lenses using Optifree RepleniSH lens solution for 28 days
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Quantify the ocular response to acute and chronic lens wear using slit lamp examination, tear assay and corneal sensitivity.
Time Frame: 5 months
|
5 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Trefford Simpson, DipOptom,MSc,PhD, University of Waterloo
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2008
Primary Completion (Actual)
June 1, 2009
Study Completion (Actual)
September 1, 2009
Study Registration Dates
First Submitted
July 24, 2008
First Submitted That Met QC Criteria
July 24, 2008
First Posted (Estimate)
July 28, 2008
Study Record Updates
Last Update Posted (Actual)
November 26, 2019
Last Update Submitted That Met QC Criteria
November 24, 2019
Last Verified
November 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- P/289/07/B
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ametropia
-
Alcon ResearchCompletedRefractive AmetropiaUnited States
-
Alcon ResearchCompletedRefractive AmetropiaUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive AmetropiaUnited States
-
European Vision Institute Clinical Research NetworkCompletedNormal Subjects, AmetropiaSpain
-
Alcon ResearchCompletedMyopia | Hyperopia | Refractive AmetropiaUnited States
-
Bausch & Lomb IncorporatedCompletedRefractive AmetropiaUnited States
-
Alcon ResearchCompletedRefractive AmetropiaUnited States
-
Bausch & Lomb IncorporatedCompletedRefractive AmetropiaUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive AmetropiaUnited States
-
Unicon Optical Co. Ltd.Recruiting
Clinical Trials on Purevision Lenses with ReNu Multiplus
-
Southern California College of Optometry at Marshall...Alcon ResearchCompletedContact Lens Solution ToxicityUnited States
-
Alcon ResearchCompletedCorneal StainingUnited States
-
University Hospitals Cleveland Medical CenterAlcon ResearchCompletedMyopia | Hyperopia | Corneal Infiltrative EventsUnited States
-
Alcon ResearchCompletedRefractive Error | Astigmatism | MyopiaUnited States
-
Alcon ResearchCompletedConjunctival StainingUnited States
-
Alcon ResearchCompletedContact Lens MoistureUnited States
-
Alcon ResearchCompletedContact Lens Related Dry EyeUnited States
-
Alcon ResearchCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Bausch & Lomb IncorporatedCompleted